麻豆视频

Europe Ultrasound Devices Market Trends and Insights

Increased Adoption of Diagnostic Imaging in Primary Care

Primary-care physicians across Western Europe are equipping surgeries with handheld or laptop ultrasound devices to shorten referral queues and triage non-urgent complaints on-site. Germany already has 98% penetration in general practices, setting a reference model for neighboring health systems.^{[1]Judith Wachtler et al., 鈥淯ltrasound Availability in Primary Care in Germany,鈥� BMC Primary Care, bmc.org} The United Kingdom鈥檚 Integrated Diagnostics and Pathology framework is placing portable scanners in 155 Community Diagnostic Centres, allowing musculoskeletal and abdominal scans to be completed outside hospitals, thereby relieving pressure on radiology departments. Eastern Europe remains behind the curve because budgets and reimbursement codes still favor hospital-centric imaging. Whether ministries adjust tariff schedules for primary-care scans will determine how quickly adoption spreads to that region.

Growing Burden of Chronic Diseases

Cardiovascular disease continues to cause 45% of all European deaths, which in turn generates steady demand for repeat echocardiography and Doppler studies to monitor heart-failure progression.^{[2]European Society of Cardiology, 鈥淐ardiovascular Disease Statistics 2024,鈥� escardio.org} Oncology pathways increasingly rely on ultrasound-guided needle biopsies and contrast-enhanced exams for real-time characterization of liver and kidney tumors, enabling clinicians to avoid radiation-based CT when diagnostic performance is equal. Diabetes complications prompt vascular screening that identifies peripheral artery disease earlier, thereby expanding the overall pool of patients examined. Because each chronic patient now undergoes multiple imaging events per year, utilization rates rise even though the continent鈥檚 population is aging rather than growing. Portable probes are well-suited for at-home monitoring and community follow-up visits, which outpace stationary installations in hospitals.

Miniaturization and Point-of-Care Uptake in Ambulances and Home-Care

Handheld probes retailing below USD 5,000, such as the Butterfly iQ3 and GE HealthCare Vscan Air SL, transmit high-quality images directly to smartphones, enabling paramedics to assess internal bleeding or cardiac function before patients arrive at emergency rooms. Clarius devices add AI auto-measurements and direct DICOM export over Wi-Fi, supporting home-nursing teams that need rapid bladder or deep-vein scans. The United Kingdom published 54 procurement notices for ultrasound in 2025, allocating a significant share to portable gear destined for its community hubs. Payment gaps persist, however, because many insurers reimburse handheld scans at only 50鈥�70% of cart exam rates or not at all, discouraging uptake in smaller practices. Compliance with ISO 13485 and IEC 60601 standards helps vendors clear regulatory hurdles; however, broad adoption hinges on updated fee schedules.

AI-Enabled Workflow Efficiencies Reducing Exam Time

Cart platforms, such as Philips EPIQ Elite and Samsung Medison HERA W10 Elite, automate labor-intensive measurements, including ejection fraction and fetal biometry, thereby reducing the sonographer's workload by approximately 25% per study. Siemens Healthineers鈥� latest ACUSON Sequoia utilizes deep learning in liver elastography, enabling clinicians to characterize fibrosis in fewer sweeps.^{[3]Siemens Healthineers, 鈥淎CUSON Sequoia Deep Learning Release,鈥� siemens-healthineers.com} Despite these gains, a 2024 systematic review revealed that many commercial algorithms exhibit domain shift when applied outside the institution where they were trained, underscoring the importance of multi-center validation. The EU MDR now classifies most adaptive algorithms as high-risk software, obligating the submission of prospective clinical evidence, which elongates the product approval timeline. The European Society of Radiology is developing standard evaluation metrics to accelerate acceptance once those datasets become available.

Fragmented Reimbursement for Handheld Devices

Most European tariff systems were designed for hospital radiology, so a handheld abdominal scan in a community clinic can be reimbursed at 30鈥�50% below the equivalent cart-based code, or not reimbursed at all. NICE endorsed point-of-care ultrasound in emergency departments in 2024, yet NHS billing tables have not been updated, forcing trusts to either absorb the cost or restrict its deployment. France and Spain maintain dual fee schedules that pay radiologist-performed exams significantly more than clinician-performed studies, limiting the uptake of handheld devices beyond urban hospitals. Eastern European funds are even tighter, and payers often refuse coverage for any ultrasound conducted outside a radiology department, curbing handheld adoption where it might otherwise offset sonographer shortages.

Shortage of Certified Sonographers Across Eastern Europe

A European Commission study reveals that the region is short 1.2 million healthcare workers, including a significant shortfall of radiographers and sonographers. In 2024, the European Society of Radiology reported that 45% of radiologists are over 51 years old, and 19% will retire within the next five years. Poland now posts non-urgent ultrasound waits of up to eight weeks, driving patients either to private imaging chains or across the German border. The annual training output of roughly 700 sonographers across Eastern Europe is insufficient to backfill these departures, leaving new scanners idle due to a lack of operators. Western Europe feels a ripple effect as skilled staff migrate westward for higher wages, so workforce ceilings ultimately limit equipment sales throughout the union.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Application: Prenatal Screening Fuels Rapid Obstetric Growth

In 2025, radiology and general imaging maintained a 24.31% share of the European ultrasound devices market, thanks to their entrenched workloads in hospital departments, including abdominal, soft-tissue, and vascular imaging. However, obstetrics and gynecology are scaling fastest at a 7.48% CAGR because national prenatal protocols now recommend three to four scans per pregnancy and add 3D/4D imaging for anomaly detection. The European ultrasound devices market size tied to obstetric endpoints is therefore rising more quickly than radiology volumes, especially in Spain and Italy, where maternal screening investments are part of post-pandemic recovery budgets. A simultaneous surge in cardiac Doppler and echocardiography is driven by heart-failure monitoring: cardiovascular disease causes 45% of European deaths, and each case necessitates serial imaging. Emergency and critical-care teams accelerate uptake of FAST protocols, while musculoskeletal clinics deploy high-frequency probes as cheaper, faster alternatives to MRI for tendon tears. 

Clinical diversification broadens revenue streams because every incremental application requires at least one dedicated transducer. This momentum benefits vendors that offer modular platforms flexible enough to support obstetrics, vascular and anesthesiology workflows on the same console. Conversely, radiology growth is capped by staff shortages, creating a ceiling on the number of additional exams that hospital departments can absorb. Portable scanners further tilt share toward obstetrics because prenatal visits often occur in outpatient settings where mobility is prized.

By Technology: 3D/4D Retains Lead, HIFU Climbs From Niche to Growth Engine

Three-dimensional and four-dimensional imaging captured 44.73% of the European ultrasound devices market size in 2025, owing to its dominance in fetal, breast, and musculoskeletal use cases. Vendors refine algorithms that render lifelike fetal images within seconds, deepening demand among expectant parents and clinicians. At the same time, HIFU is expanding at a 7.97% CAGR by offering a non-invasive alternative for uterine fibroid and prostate cancer ablation, reducing hospitalization and surgical risk. Doppler modalities remain essential for vascular assessments, whereas elastography is emerging as a preferred non-invasive method to stage liver fibrosis, aligning with EASL practice guidelines. 

As reimbursement agencies increasingly cover therapeutic ultrasound, vendors are packaging diagnostic and ablative capabilities on the same platform, thereby elevating average selling prices. European notified bodies nevertheless demand robust safety data for each indication, lengthening the time to market. Vendors capable of bundling 3D/4D, Doppler, elastography, and HIFU on a unified upgradeable architecture stand to maximize replacement-cycle sales as hospitals streamline fleets.

By Device Portability: Compact Portable Gains Ground Over Heavy Carts

Cart and trolley systems still accounted for 59.38% of the European ultrasound devices market size in 2025, as they offer premium image quality, broad probe support, and high-end features such as contrast-enhanced ultrasound. Yet compact portable units are expanding at a 6.54% CAGR as ASCs and emergency departments prioritize mobility when space and budget are limited. Handheld products now constitute the fastest-growing sub-segment: devices priced between USD 2,000 and USD 5,000 appeal to primary-care clinics and paramedic services that previously could not justify a USD 50,000 cart. The European ultrasound devices market share of handhelds remains small today, yet month-to-month unit shipments are rising steeply. 

This shift in portability forces incumbent OEMs to defend their margins by releasing scaled-down versions of their flagship consoles, while newcomer brands compete on subscription pricing and smartphone integration. Hospitals are also acquiring portable units as backup devices for resuscitation bays and isolation rooms, so a single institution may purchase both categories, blurring historical segmentation lines.

By End User: Outpatient Migration Propels ASC Demand

Hospitals accounted for 54.26% of total spending in 2025; however, ASCs delivered the strongest CAGR at 9.44%, as payers increasingly reward lower-cost outpatient pathways. Diagnostic imaging centers pick up the overflow from hospitals burdened by staffing shortages, while home-care agencies integrate handheld probes for monitoring chronic diseases. Italy has earmarked EUR 76 million to equip outpatient centers with nearly 1,000 scanners, demonstrating the state's commitment to decentralized imaging. Spain鈥檚 forthcoming 150 diagnostic sites reinforce this trend, and the United Kingdom鈥檚 Community Diagnostic Centres embed scanners within primary-care networks. 

Hospitals remain irreplaceable for high-acuity exams such as intra-operative cardiac imaging, but every shift toward outpatient care shrinks the cart addressable market and enlarges the portable category. Vendors that tailor service contracts and financing to ASC purchasing cycles will capture this momentum.

Geography Analysis

Germany鈥檚 leadership is built on decades of primary-care adoption, which now drives steady upgrade cycles as practices transition from 2D to AI-enabled 3D/4D systems. Carbon-reduction rules further motivate hospitals to select ultrasound over CT, ensuring that the modality鈥檚 installed base continues to expand in radiology suites. The United Kingdom is shifting routine imaging into community hubs to address persistent wait-time overruns; the award of portable probe lots in 2025 confirms the trend. France stays on a moderate trajectory because reimbursement is stable, but adoption of handheld devices by general practitioners is slower due to fee gaps.

Spain is setting the regional growth pace through sizeable public-investment tranches that earmark new diagnostic centers for underserved provinces and favor ultrasound as the default first-line tool. Italy mirrors this push by dedicating recovery funds to ASC equipment. Across Eastern Europe, limited reimbursement and a thin pool of sonographers cap usage; yet, handhelds offer a cost-effective bridge when capital budgets are tight. This geographic diversity demands tailored channel strategies: high-spec carts flourish in Western teaching hospitals, whereas simple portables unlock incremental volume in Southern clinics and Eastern ambulatory sites.

Regulatory Landscape

Ultrasound systems marketed across Europe are governed by the EU Medical Device Regulation (MDR) (Regulation (EU) 2017/745), applicable since 26 May 2021, which sets general safety and performance requirements and requires manufacturers to compile technical documentation and undergo conformity assessment for CE marking. For connected and AI-enabled ultrasound workflows, MDR expectations around clinical evidence and post-market surveillance increase the documentation and validation burden, contributing to longer certificate timelines that can spill into procurement schedules.

A key operational milestone in the MDR infrastructure is EUDAMED, which is being rolled out in phases under the transitional provisions updated via Regulation (EU) 2024/1860. The European Commission indicates the EUDAMED UDI/Devices module becomes mandatory to use from 28 May 2026, raising the importance of UDI readiness, data quality, and system integration for manufacturers and authorized representatives placing ultrasound devices on the EU market. On the engineering side, safety and essential performance expectations are commonly addressed through applicable standards for diagnostic and monitoring ultrasound equipment, including EN IEC 60601-2-37:2024 (diagnostic and monitoring scope), supporting conformity to essential requirements when used within a compliant quality-management system (for example, ISO 13485).

Market Opportunities and Future Outlook

A clear commercialization opening is forming around AI-enabled workflow automation and high-throughput clinical environments, where providers face staffing constraints and seek shorter exam times and more standardized measurements. In June 2026, Philips introduced the Alturion ultrasound system in Europe with AI-powered workflows for high-volume settings, while Canon Medical Systems showcased Aplio me X at Euroson 2026 with a focus on AI-assisted workflows and battery-powered portability. These launches reinforce demand for platforms that combine imaging performance with embedded automation, connectivity, and easier deployment across outpatient hubs, emergency settings, and community diagnostic sites.

Women鈥檚 health, prenatal screening, and interventional workflows provide additional white space as vendors extend ultrasound from diagnostic imaging into procedure guidance and decision support. BrightHeart announced CE mark and a European launch for its B-Right AI platform for prenatal ultrasound in June 2026, indicating that MDR-cleared software layers are moving into routine clinical adoption pathways, not only research pilots. Product introductions at ECR 2026, including Esaote鈥檚 MyLab E85 and MyLab C30 GTS Edition positioned for interventional radiology, underline the opportunity for vendors that bundle advanced guidance features, transducer ecosystems, and enterprise imaging integration to fit outpatient growth, ASC purchasing cycles, and hospital decarbonization priorities that favor lower-emission modalities.